No results for ‘’
Medplus Health Services Ltd
₹818.30
(2.09%)
Thu, 09 Jul 2026, 10:14 pm
Retail Trade
Drugstore Chains
24.5KMedplus Health Services EV/EBITDA Ratio
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 118.15 | 156.56 | 126.39 | 60.65 |
| Price to book ratio | 0 | 0 | 0 | 8.47 | 5.20 | 5.22 | 5.22 |
| Price to sales ratio | 0 | 0 | 0 | 3 | 1.71 | 1.47 | 1.49 |
| Price to cash flow ratio | 0 | 0 | 0 | 66.78 | 70.31 | 52.62 | 16.44 |
| Enterprise value | 0 | 0 | 0 | 11476Cr | 8403Cr | 9119Cr | 9796Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 41.95 | 31.40 | 25.60 | 20.01 |
| Debt to equity ratio | 1.47 | 0.90 | 0.81 | 0.57 | 0.60 | 0.64 | 0.64 |
| Return on equity % | 0 | 0.53 | 10.15 | 8.92 | 3.42 | 4.27 | 9.06 |
Medplus Health Services Ltd Enterprise Value to EBITDA Ratio
The Medplus Health Services Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Medplus Health Services Ltd's valuation, profitability, and overall financial performance. Tracking the Medplus Health Services Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Medplus Health Services Ltd (NSE: MEDPLUS, BSE: 543427) is currently trading at ₹818.30, with a market capitalization of ₹9622.98Cr. As a leading company in the Retail trade sector and Drugstore chains industry, monitoring the Medplus Health Services Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Medplus Health Services Ltd Enterprise Value to EBITDA Ratio Current Value
The current Medplus Health Services Ltd Enterprise Value to EBITDA Ratio stands at 20.01.
The Medplus Health Services Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Medplus Health Services Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Medplus Health Services Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 20.01
- 2023: 25.60
- 2022: 31.40
- 2021: 41.95
- 2020: 0
The decline in Medplus Health Services Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Medplus Health Services Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Medplus Health Services Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Medplus Health Services Ltd.
Medplus Health Services Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Medplus Health Services Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Medplus Health Services Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Medplus Health Services Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.